Skip to main content
. 2023 Oct 26;16(21):6881. doi: 10.3390/ma16216881

Table 8.

Hemocompatibility tests, summarized from [65].

Test Name Recommended for Purpose
Hemolysis assay All devices except those that do not have direct contact with blood cells Measures the damage to red blood cells when exposed to materials or their extracts and compares it to positive and negative controls.
Coagulation assays All devices with blood Measures the effect of the test article on human blood coagulation time.
Prothrombin Time Assay All devices with blood General screening test for the detection of coagulation abnormalities in the extrinsic pathway.
Partial Thromboplastin Time Assay All devices with blood Detects coagulation abnormalities in the intrinsic pathway.
Thrombogenicity test Devices unsuited to in vivo Required tests in coagulation, platelets, hematology, and complement system categories. The most common test for thrombogenicity is the in vivo method.
Complement activation Implant devices In vitro assay to measure complement activations in the human plasma due to exposure of the plasma to the test article or an extract. Measures complement activation.